Event-Driven Stocks

Surrozen, Inc./DE

SRZNNasdaq

Healthcare · Biological Products, (No Diagnostic Substances) · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 2 good● 5 warning● 3 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$3.5M$10.7M$0$12.5M$0—
Operating income−$42.1M−$25.5M−$45.8M−$44.3M−$54.4M−$438,756
Net income−$242.0M−$63.6M−$43.0M−$36.0M−$54.6M−$441,255
Total assets$98.7M$48.5M$46.1M$89.4M$137.2M$93.8M
Total liabilities$286.5M$69.8M$8.1M$13.4M$27.5M$3.5M
Equity−$187.8M−$21.4M$37.9M$76.0M$109.7M$0
EPS (diluted)$-32.37$-21.67$-21.33$-15.56$-2.21—
Shares out.3.3M3.2M30.1M35.1M35.0M18.3M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
−1210.6%
Net margin
−6960.8%
Return on equity
128.9%
Return on assets
−245.1%
Return on capital (ROCE)
−47.4%
Liabilities / assets
290.2%
Debt / equity
—
Book value / share
$-57.22
Revenue growth (YoY)
−67.4%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
-15.54distress
Accruals / assets
−214.5%clean
Piotroski F-Score
2/9weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
42
/ 100
Profitability 20Growth 0Catalyst 100Earnings quality 67Financial strength 25

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →

Signs

● 3 severe● 5 warning● 2 good
  • Negative shareholder equity
  • Altman Z″ in the distress zone
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Revenue declined year-over-year
  • High leverage (liabilities > 70% of assets)
  • Negative operating cash flow
  • Strong return on equity (>15%)
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Insider transactions

SEC Form 4 · most recent
4 acquisitions1 disposals1 open-market buy(s)net +28,446 shares · last 5
InsiderDateTypeSharesPrice
Li YangOfficer — Exec. Vice President, ResearchMay 1, 2026Option exercise4,375—
Williams Charles OOfficer — Chief Operating OfficerMay 1, 2026Option exercise5,625—
Parker Craig COfficer — Chief Executive OfficerMay 1, 2026Option exercise12,500—
Li YangOfficer — Exec. Vice President, ResearchMar 31, 2026Gift1,666$0.00
Tcg Crossover Gp Ii, Llc10% ownerMar 23, 2026Buy7,612$24.90

Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 2026546,2246.4-3.4%
Apr 30, 2026565,3074.7+30.1%
Apr 15, 2026434,5713.1+25.8%
Mar 31, 2026345,4504.4+6.0%
Mar 13, 2026325,8503.0+12.9%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (4)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.